References
- Knox A, McLure N. Fibroids and fertility: A review of the evidence. Expert Review of Obstetrics & Gynecology. 2012;7:31–9.
- McLucas B, Goodwin S, Adler L, Rappaport A, Reed R, Perrella R. Pregnancy following uterine fibroid embolization. Int J Gynaecology Obstetrics. 2001;74:1–7; Epub 2001/06/30.
- Hehenkamp WJ, Volkers NA, Broekmans FJ, de Jong FH, Themmen AP, Birnie E, Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy. Hum Reprod. 2007;22:1996–2005; Epub 2007/06/22.
- Tulandi T, Sammour A, Valenti D, Child TJ, Seti L, Tan SL. Ovarian reserve after uterine artery embolization for leiomyomata. Fertil Steril. 2002;78:197–8; Epub 2002/07/04.
- George K, Kamath MS. Fertility and age. J Human Reproductive Sci. 2010;3:121–3; Epub 2011/01/15.
- Seli E. Infertility. Arici A, editor. Oxford, UK: Blackwell Publishing Ltd, 2011. p 204.
- Seifer DB, Baker VL, Leader B. Age-specific serum anti-Mullerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil Steril. 2011;95:747–50; Epub 2010/11/16.
- La Marca A, Stabile G, Artenisio AC, Volpe A. Serum anti-Mullerian hormone throughout the human menstrual cycle. Human Reproduction. 2006;21:3103–7; Epub 2006/08/23.
- Kristensen SL, Ramlau-Hansen CH, Andersen CY, Ernst E, Olsen SF, Bonde JP, The association between circulating levels of antimullerian hormone and follicle number, androgens, and menstrual cycle characteristics in young women. Fertil Steril. 2012;97:779–85; Epub 2012/01/17.
- Ravina JH, Vigneron NC, Aymard A, Le Dref O, Merland JJ. Pregnancy after embolization of uterine myoma: report of 12 cases. Fertil Steril. 2000;73:1241–3; Epub 2000/06/17.
- Walker WJ, McDowell SJ. Pregnancy after uterine artery embolization for leiomyomata: a series of 56 completed pregnancies. A J Obstetrics Gynecol. 2006;195:1266–71; Epub 2006/06/27.
- Pron G, Mocarski E, Bennett J, Vilos G, Common A, Vanderburgh L, Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial. Obstet Gynecol. 2005;105:67–76; Epub 2004/12/31.
- Hok YHY, Cha SW, Park CW, Yang KM, Song IO, Koong MK, Age specific Anti-Mullerian hormone levels in 1,298 Korean women with regular menstruation. Clin Exp Reprod Med. 2011;38:93–7.
- de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002;77:357–62; Epub 2002/02/01.
- van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril. 2005;83:979–87; Epub 2005/04/12.
- Kunt C, Ozaksit G, Keskin Kurt R, Cakir Gungor AN, Kanat-Pektas M, Kilic S, Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization. Archives Gynecology Obstetrics. 2011;283:1415–21; Epub 2011/05/13.